Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group (Q34730962)
scientific article
Language:
Current Data About Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group
(P31) (Q13442814)
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

(P304) 662-667
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

(P407) (Q1860)

(P433) 4
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

(P478) 43
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

(P577) Thursday, April 1, 1993
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

(P921) (Q269829)

(Q6934595)

(Q18555066)

(Q8277)

(Q161238)

(P1433) (Q1161692)
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

(P1476) "Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group" (language: en)
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

(P2093) Paty DW
(P1545) 1
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

Li DK
(P1545) 2
(P248)
(P698) 8469319
(P813) Friday, August 4, 2017

other details
description scientific article

External Links
(P356) 10.1212/WNL.43.4.662
(P698) 8469319